Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Simaravibart

(Synonyms: MAD-0004J08) Copy Product Info
🥰Excellent

Synonyms: MAD-0004J08

Catalog No. T80575 Copy Product Info
🥰Excellent
Simaravibart (MAD-0004J08), an IgG1κ monoclonal antibody, specifically targets the receptor-binding domain of the SARS-CoV-2 spike (S) glycoprotein [1].
Simaravibart
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$2234-6 weeks4-6 weeks
5 mg$6724-6 weeks4-6 weeks
10 mg$1,0804-6 weeks4-6 weeks
25 mg$1,9204-6 weeks4-6 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Simaravibart (MAD-0004J08), an IgG1κ monoclonal antibody, specifically targets the receptor-binding domain of the SARS-CoV-2 spike (S) glycoprotein [1].
SynonymsMAD-0004J08
Reactivity
Virus
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetSARS-CoV-2
Chemical Properties
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: